Mika Scheinin
MD, PhD, Professor Emeritus
Bioanalytics; Clinical Pharmacology; Drug Development; Positron Emission Tomography; Research Ethics
- Physiological, psychological, and performance effects of office noise (2019)
- International Congress on Acoustics
- Premedication with intranasal dexmedetomidine decreases thiopental requirements in sedation of pediatric patients for magnetic resonance imaging: a retrospective study (2019)
- BMC Anesthesiology
- Radiosynthesis and Preclinical Evaluation of an α2A-Adrenoceptor Tracer Candidate, 6-[18F]Fluoro-marsanidine (2019)
- Molecular Imaging and Biology
- Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study (2019)
- Lancet Gastroenterology and Hepatology
- Serotonerginen transmissio (2019) Lääketieteellinen farmakologia ja toksikologia Mika Scheinin, Esa R. Korpi, Ullamari Pesonen
- Serotoniinin biologiset vaikutukset (2019) Lääketieteellinen farmakologia ja toksikologia Mika Scheinin, Esa R. Korpi, Ullamari Pesonen
- Soluunottoon perustuva kohdennettu neurotoksisuus (2019) Lääketieteellinen farmakologia ja toksikologia Outi Salminen, Mika Scheinin
- Synteettiset orgaaniset fosforiyhdisteet (2019) Lääketieteellinen farmakologia ja toksikologia Outi Salminen, Petteri Piepponen, Mika Scheinin
- Treating gambling disorder with as needed administration of intranasal naloxone: A pilot study to evaluate acceptability, feasibility and outcomes (2019)
- BMJ Open
- Upper Airway Collapsibility during Dexmedetomidine and Propofol Sedation in Healthy Volunteers: A Nonblinded Randomized Crossover Study (2019)
- Anesthesiology



